Papers - YONEYAMA Tohru
-
C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.
Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 26 ( 10 ) 992 - 998 2019.7
-
Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer.
Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C
IJU case reports 2 ( 4 ) 236 - 239 2019.7
-
Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.
Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shunji Narumi, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama
Clinical and experimental nephrology 23 ( 6 ) 807 - 813 2019.6
-
Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.
Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shunji Narumi, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama
Clinical and experimental nephrology 23 ( 6 ) 807 - 813 2019.6
-
Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.
Okita K, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C
Clinical genitourinary cancer 17 ( 3 ) e440 - e446 2019.6
-
Renal cell carcinoma in a lumbar ectopic kidney.
Itsuto Hamano, Shingo Hatakeyama, Osamu Soma, Yusuke Ishibashi, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shoji Nishimura, Takuya Koie, Chikara Ohyama
IJU case reports 2 ( 3 ) 124 - 127 2019.5
-
Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.
Teppei Matsumoto, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Kazuhisa Hagiwara, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama
BJU international 123 ( 5 ) 877 - 884 2019.5
-
尿路結石形成に関与する尿中糖鎖変異オステオポンチン(PolyLac-OPN)のバイオマーカーの可能性
阿南 剛, 米山 徹, 畠山 真吾, 飛澤 悠葵, 米山 美穂子, 岩村 大径, 伊藤 淳, 海法 康裕, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 鈴木 唯司, 佐藤 信, 大山 力
日本内分泌学会雑誌 95 ( 1 ) 379 - 379 2019.4
-
Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.
Matsumoto T, Hatakeyama S, Narita T, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 26 ( 4 ) 522 - 523 2019.4
-
尿路結石形成に関与する尿中オステオポンチンの糖鎖変異
阿南 剛, 米山 徹, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 古家 琢也, 鈴木 唯司, 佐藤 信, 大山 力
日本尿路結石症学会誌 17 ( 2 ) 117 - 119 2019.3
-
前立腺がんの過剰診断を克服する診断マーカーの開発
米山 徹, 大山 力
腎臓内科・泌尿器科 9(4) 349 - 357 2019
-
Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Iwamura H, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C
European urology focus 4 ( 6 ) 946 - 953 2018.12
-
Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.
Naoki Fujita, Takuya Koie, Yasuhiro Hashimoto, Takuma Narita, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Kazuhisa Hagiwara, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Chikara Ohyama
International urology and nephrology 50 ( 11 ) 1999 - 2005 2018.11
-
Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.
Naoki Fujita, Takuya Koie, Yasuhiro Hashimoto, Takuma Narita, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Kazuhisa Hagiwara, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Chikara Ohyama
International urology and nephrology 50 ( 11 ) 1999 - 2005 2018.11
-
Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.
Teppei Matsumoto, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Kazuhisa Hagiwara, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama
BJU international 2018.9
-
Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.
Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Toshikazu Tanaka, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 25 ( 9 ) 817 - 824 2018.9
-
Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers.
K V Yogesh, Toshiya Kamiyama, Chikara Ohyama, Tohru Yoneyama, Kazuhiro Nouso, Satoshi Kimura, Hiroshi Hinou, Shin-Ichiro Nishimura
MedChemComm 9 ( 8 ) 1351 - 1358 2018.8
-
Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers.
Yogesh KV, Kamiyama T, Ohyama C, Yoneyama T, Nouso K, Kimura S, Hinou H, Nishimura SI
MedChemComm 9 ( 8 ) 1351 - 1358 2018.8
-
Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.
Itsuto Hamano, Shingo Hatakeyama, Rika Nakamura, Rie Fukuhara, Daisuke Noro, Toshikazu Tanaka, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yoshihito Yokoyama, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 25 ( 9 ) 817 - 824 2018.7
-
Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.
Koichi Kido, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama
European urology focus 2018.5